Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C

Biochemical and Biophysical Research Communications

Volumn 286, Issue 4, 2001, Pages 764-770

  Knapp, Lauren T ^a   Kanterewicz, Beatriz I ^a   Hayes, Emma L ^a   Klann, Eric ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Hippocampus; Neurodegenerative disease; Nitric oxide; Protein kinase C; Reactive nitrogen species; Reactive oxygen species; Superoxide

Indexed keywords

N ACETYL S NITROSOPENICILLAMINE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; S NITROSOCYSTEINE;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOPRECIPITATION; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0034816642     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5448     Document Type: Article

References (52)

1. Studies and perspectives of protein kinase C
2. A biochemist's view of long-term potentiation
3. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding
4. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex
5. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
6. 2+-activated and phospholipid-dependent protein kinase
7. A putative phosphatidylserine binding motif is not involved in the lipid regulation of protein kinase C
8. Use of synthetic peptide neurogranin(28-43) as a selective protein kinase C substrate in assays of tissue homogenates
9. Mechanism of protein kinase C activation during the induction and maintenance of long-term potentiation probed using a novel peptide substrate
10. A role for superoxide in protein kinase C activation and induction of long-term potentiation
11. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content
12. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly
13. Reactive oxygen species and the central nervous system
14. 2+- and phospholipid-independent activation of protein kinase C by selective modification of the regulatory domain
15. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates
16. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite
17. Peroxynitrite-mediated inactivation of maganese superoxide dismutase involved nitration and oxidation of critical tyrosine residues
18. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1
19. Hydrogen peroxide formation by reaction of peroxynitrite with Hepes and related tertiary amines
20. The molecular heterogeneity of protein kinase C and its implication for cellular regulation
21. Susceptibility of protein kinase C to oxidative inactivation: Loss of both phosphotransferase activity and phorbol diester binding
22. Activation of rat brain protein kinase C by lipid oxidation products
23. Oxidant-induced activation of protein kinase C in UC11MG cells
24. Activation of protein kinase C by oxidized diacylglycerols
25. Peroxynitrite induces tyrosine nitration and modulates tyrosine phophorylation of synaptic proteins
26. Decreased levels of protein kinase C in Alzheimer brain
27. Protein kinases and phosphorylation in neurologic disorders and cell death
28. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients
29. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease
30. Reversal of Swedish familial Alzheimer's disease mutant phenotype in cultured cells treated with phorbol 12,13-dibutyrate
31. 2+-independent protein kinase C changes in the brains of patients with Alzheimer's disease
32. Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator
33. Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels
34. Decrease of protein kinase C in the spinal motor neurons of amyotrophic lateral sclerosis
35. Activation of PKC reversed apparent NMDA receptor reduction in ALS
36. -2 and protein kinase C
37. Second messenger systems in brains of patients with Parkinson's or Huntington's disease
38. Evidence for neuronal oxidative damage in Alzheimer's disease
39. Widespread peroxynitrite-mediated damage in Alzheimer's disease
40. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
41. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study
42. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALD/MND
43. Upregulation of protein-tyrosine nitration in the anterior horn of amyotrophic lateral sclerosis
44. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
45. Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture
46. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicated a region-specific accumulation
47. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing ta human Cu/Zn SOD mutation
48. Oxidative stress in Huntington's disease
49. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
50. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
51. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dinitrotyrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine-treated mice, a model of oxidative stress in Parkinson's disease
52. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitriproprionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine